These tests look for how much m-protein is in your blood, and what kind of m-protein you have. People with MGUS do not have symptoms or signs of multiple myeloma. Some people feel peripheral ...

Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM ... microenvironment are reflected in the peripheral blood lymphocyte count and peripheral blood ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into optimising anti-CD38 antibody-containing quadruplet regimens (quads) for ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

In the phase 3, randomized CARTITUDE-4 trial involving patients with lenalidomide-refractory multiple myeloma who had ... positive T-cell counts in peripheral blood (blue line) and soluble B ...

But after a seemingly random finger fracture, his doctor tested him for elevated protein levels in his blood and told him he had a form of cancer called multiple myeloma. It was sort of an out-of ...